- Home
- COP vs SYK Comparison
COP vs SYK Comparison
Compare COP & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COP
- SYK
- Stock Information
- Founded
- COP 1917
- SYK 1941
- Country
- COP United States
- SYK United States
- Employees
- COP N/A
- SYK N/A
- Industry
- COP Integrated oil Companies
- SYK Medical/Dental Instruments
- Sector
- COP Energy
- SYK Health Care
- Exchange
- COP Nasdaq
- SYK Nasdaq
- Market Cap
- COP 122.2B
- SYK 146.1B
- IPO Year
- COP N/A
- SYK N/A
- Fundamental
- Price
- COP $113.42
- SYK $385.64
- Analyst Decision
- COP Buy
- SYK Buy
- Analyst Count
- COP 17
- SYK 19
- Target Price
- COP $137.38
- SYK $395.42
- AVG Volume (30 Days)
- COP 5.3M
- SYK 1.4M
- Earning Date
- COP 10-31-2024
- SYK 10-29-2024
- Dividend Yield
- COP 2.75%
- SYK 0.83%
- EPS Growth
- COP N/A
- SYK 38.37
- EPS
- COP 8.44
- SYK 9.33
- Revenue
- COP $56,924,000,000.00
- SYK $21,974,000,000.00
- Revenue This Year
- COP N/A
- SYK $11.34
- Revenue Next Year
- COP $9.85
- SYK $8.11
- P/E Ratio
- COP $13.44
- SYK $41.35
- Revenue Growth
- COP N/A
- SYK 10.51
- 52 Week Low
- COP $101.30
- SYK $285.79
- 52 Week High
- COP $135.18
- SYK $398.20
- Technical
- Relative Strength Index (RSI)
- COP 60.25
- SYK 63.35
- Support Level
- COP $112.25
- SYK $380.21
- Resistance Level
- COP $114.46
- SYK $398.20
- Average True Range (ATR)
- COP 2.08
- SYK 7.79
- MACD
- COP 0.42
- SYK 1.38
- Stochastic Oscillator
- COP 82.31
- SYK 68.91
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.